ST2在急性心力衰竭中的预后价值被引量：17

ST2 and prognosis in acute heart failure

下载PDF

导出

摘要 ST2与IL-33结合能够减少心肌纤维化，抑制心肌肥大，减少心肌凋亡及改善心脏功能。sST2可以欺骗性地与IL-33结合抑制心肌保护作用。截止目前，发现ST2在社区人群中的参考值范围与性别有关，与年龄关系不确切；ST2对于急性心力衰竭（AHF）的诊断价值不大，却能较好地独立预测AHF患者不良心血管事件的发生，尤其是死亡和心力衰竭再住院；连续监测ST2浓度可能预测价值更大，而且有可能在指导治疗方面发挥重要作用。 ST2 could reduce myocardial fibrosis, inhibit myocardial hypertrophy, prevent myocardial apoptosis and improve heart function by the binding of IL - 33. sST2 avidly binds IL - 33 which results in interruption of the cardioprotective interaction. At present, firstly, ST2 in community population is certainly related to gender, but unclearly to age. Moreover, the diagnostic value of ST2 is negligible in patients with acute heart failure, but it can independently predict adverse cardiovascular events in those, especially the death and rehospitalization for worsen heart function. The last, serial measurement of the ST2 might play an important role in the prognosis and guidance of treatment.

作者孟冲商德亚王娟

机构地区山东大学附属省立医院

出处《中国急救医学》 CAS CSCD 北大核心 2018年第1期41-45,共5页 Chinese Journal of Critical Care Medicine

关键词急性心力衰竭(AHF) ST2 预后 Acute heart failure（AHF） ST2 Prognosis

分类号 R541.6 [医药卫生—心血管疾病]

引文网络
相关文献

参考文献2

1王运红,周琼,安涛,张荣成,黄燕,甘天翊,梁拓,赵雪梅,刘妮妮,张宇辉,张健.中国社区人群可溶性ST2血浆水平的参考值范围及影响因素[J].中华心血管病杂志,2015,43(10):900-903. 被引量：11
2徐亚妹,葛均波.新型心衰标志物sST2的生物学特征和临床意义[J].中华检验医学杂志,2015,38(7):498-501. 被引量：35

二级参考文献43

1周京敏.心力衰竭生化标志物[EB/OL].东方心脏病会议.[2010-05-28].http://www.occmd.org/view_detail.aspx?id=2678.
2Roger VL, Go AS, Lloyd-Jones DM, et al. Heart disease and stroke statistics--2012 update: a report from the American Heart Association[ J]. Circulation, 2012, 125( 1 ) : e2-e220.
3Daniels LB, Maisel AS. Natriuretic peptides [ JJ. J Am Coll Cardiol, 2007, 50(25), 2357-2368.
4Chen AA, Wood MJ, Krauser DG, et al. NT-proBNP levels, echocardiographic findings, and outcomes in breathless patients: results from the ProBNP Investigation of Dyspnoea in the Emergency Department (PRIDE) echzcardiographic substudy [J]. Eur Heart J, 2006, 27(7) : 839-845.
5Januzzi JL Jr, Rehman S, Mueller T, et al. Importance of biomarkers for long-term mortality prediction in acutely dyspneic patients[J]. Clin Chem, 2010, 56(12) : 1814-1821.
6van Kimmenade RR, Januzzi JL Jr. Emerging biomarkers in heart failure[J]. Clin Chem, 2012, 58(1): 127-138.
7Wang, YC, Yu CC, Chiu FC, et al. Soluble ST2 as a biomarker for detecting stable heart failure with a normal ejection fraction in hypertensive patients[J]. J Card Fail, 2013, 19(3) : 163-168.
8Weinberg EO, Shimpo M, De Keulenaer GW, et al. Expression and regulation of ST2, an interleukin-1 receptor family member, in cardiomyocytes and myocardial infarction [ J 1. Circulation, 2002, 106(23) : 2961-2966.
9lwahana H, anagisawa K, ho-Kosaka A, et al. Different promoter usage and multiple transcription initiation sites of the interleukin-1 receptorrelated human ST2 gene in UT-7 and TM12 cells[J]. Eur J Biochem, 1999, 264(2): 397-406.
10Barksby HE, Lea SR, Preshaw PM, et al. The expanding family of interleukin-1 cytokines and their role in destructive inflammatory disorders [ J ]. Clin Exp Immunol, 2007, 149 ( 2 ) : 217-225.